Krzysztof Jamroziak, PhD, discusses findings from the phase 2 PREDATOR-MRD trial (NCT03697655).
Krzysztof Jamroziak, PhD
Advertisement
Krzysztof Jamroziak, PhD, is a hematology specialist in the Department of Hematology, Transplantology, and Internal Medicine, as well as the acting deputy head in the Department of General Hematology at the Medical University of Warsaw.
Articles by Krzysztof Jamroziak, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
5